Altered Runx1 subnuclear targeting enhances myeloid cell proliferation and blocks differentiation by activating a miR-24/MKP-7/MAPK network.
about
Cooperative and individualistic functions of the microRNAs in the miR-23a~27a~24-2 cluster and its implication in human diseasesRegulatory Roles of MAPK Phosphatases in CancerBRAF Mutation in Hairy Cell LeukemiaTET2 mutations improve the new European LeukemiaNet risk classification of acute myeloid leukemia: a Cancer and Leukemia Group B study.MicroRNAs distinguish cytogenetic subgroups in pediatric AML and contribute to complex regulatory networks in AML-relevant pathwaysmiR-24 regulates menin in the endocrine pancreasTwo novel RUNX1 mutations in a patient with congenital thrombocytopenia that evolved into a high grade myelodysplastic syndromeThyroglobulin increases thyroid cell proliferation via the suppression of specific microRNAs.Preferential star strand biogenesis of pre-miR-24-2 targets PKC-alpha and suppresses cell survival in MCF-7 breast cancer cellsDefinitive hematopoiesis requires Runx1 C-terminal-mediated subnuclear targeting and transactivation.Mitogen activated protein kinase phosphatases and cancer.Transcription factor-mediated epigenetic regulation of cell growth and phenotype for biological control and cancer.Metastatic bone disease: role of transcription factors and future targets.A network connecting Runx2, SATB2, and the miR-23a~27a~24-2 cluster regulates the osteoblast differentiation program.Cardio-miRNAs and onco-miRNAs: circulating miRNA-based diagnostics for non-cancerous and cancerous diseasesMiR-24 promotes the survival of hematopoietic cellsRUNX1 repression-independent mechanisms of leukemogenesis by fusion genes CBFB-MYH11 and AML1-ETO (RUNX1-RUNX1T1).Increased expression of miR-24 is associated with acute myeloid leukemia with t(8;21).High miR-24 expression is associated with risk of relapse and poor survival in acute leukemia.Genome-wide co-occupancy of AML1-ETO and N-CoR defines the t(8;21) AML signature in leukemic cells.miR-24-3p Suppresses Malignant Behavior of Lacrimal Adenoid Cystic Carcinoma by Targeting PRKCH to Regulate p53/p21 Pathway.DUSPs, to MAP kinases and beyond.Depletion of RUNX1/ETO in t(8;21) AML cells leads to genome-wide changes in chromatin structure and transcription factor binding.MiR-24 functions as a tumor suppressor in nasopharyngeal carcinoma through targeting FSCN1.Cytotoxicity of anthrax lethal toxin to human acute myeloid leukemia cells is nonapoptotic and dependent on extracellular signal-regulated kinase 1/2 activity.MicroRNA control of bone formation and homeostasis.MicroRNA-378-mediated suppression of Runx1 alleviates the aggressive phenotype of triple-negative MDA-MB-231 human breast cancer cells.MicroRNA-24/MODY gene regulatory pathway mediates pancreatic β-cell dysfunctionThe Role of miRNA in Haematological Malignancy.A germline point mutation in Runx1 uncouples its role in definitive hematopoiesis from differentiationThe miR-24-3p/p130Cas: a novel axis regulating the migration and invasion of cancer cells.An architectural genetic and epigenetic perspective.MicroRNAs in the midst of myeloid signal transduction.MicroRNAs in acute leukemia: from biological players to clinical contributors.MicroRNA control of myelopoiesis and the differentiation block in acute myeloid leukaemia.AML1-ETO driven acute leukemia: insights into pathogenesis and potential therapeutic approaches.RUNX1: A microRNA hub in normal and malignant hematopoiesis.Targeting deregulated epigenetic control in cancer.Non-coding RNAs: Epigenetic regulators of bone development and homeostasis.Therapeutic Targeting of microRNAs in Cancer: Future Perspectives.
P2860
Q21245705-277706D7-386B-4DFB-99CB-9670E09B660DQ26751025-419E7406-C2A8-4928-BACA-C129EB062E8BQ27014016-E0706FB2-FB21-4C9B-A57F-473C5DE02DBFQ27851621-0D3B12C3-F0C6-430D-8388-48231987C530Q28486136-80A82380-29AE-4218-BD03-1E385C3D5469Q28593937-36141814-412C-455B-AB2B-5F7B577283CBQ33422165-74A31AAE-F803-4967-AD28-0D52742734DEQ33632207-0B1BA7CA-960D-40BC-AB18-C179A1B9E5D5Q33648268-02E07922-88C2-40FE-906A-C23617D3F5E8Q33697682-EBCE9D92-C823-44C3-9E9B-27BC7327F16EQ33776906-3E73D856-5A7B-4650-B021-2F3ED44426CDQ33823421-BC2397AD-7E67-4AF5-B087-7AAEC08A93EBQ34217531-7BD24958-CD5B-4F44-A6D1-EA81B9C214F8Q34358969-CBA75707-42F6-4B79-B4D4-3A674F0108BCQ34391443-06CD8082-F4C0-42AA-8D9F-90F67EADB969Q34576525-7452B6DD-1993-4D3B-B76E-5244C26BCB5FQ34621037-37D7CFC6-DECA-4395-B0C0-B2581E775C7AQ34732919-91A44648-DA43-4FF8-94D9-8556FB40AB42Q35172553-6D38FE0D-91BA-4188-A1B2-42DCFC76DC61Q35619449-78EA7987-C81D-4040-BDE3-07B35AE83F97Q36063003-3DF4E29A-DDB0-48C9-A0DC-60021A265192Q36123161-1511E71D-4EBF-44D8-8171-1B906C3B7D18Q36166902-5DF60E10-2DB8-4B32-8892-41863E9EAC90Q36210780-85781EE5-4EA2-46D9-A657-E999E3EDC25CQ36613302-B212A10A-0C24-4F61-9403-8CA4E5E8EDF2Q36661323-BBB2EEA1-A24E-40D5-8013-5CC8ED4C8967Q37080584-5AB71DA1-01F1-4C03-95F2-E8CEE37012DDQ37110636-06B93878-A37C-4612-8AE1-97BEAB9C9808Q37422388-039449CC-6868-43BB-AE93-6102A7BE33B8Q37541710-06573F91-2D29-43C3-9520-6F5B8E70FCC5Q37719430-7F26FD8D-97CE-417D-AF22-C4144436B7B3Q37823830-9EA591A1-0C43-428C-A507-2791E62A4915Q37875000-8E7B69F3-E22D-4DE3-AE51-6D488388D60EQ37893954-540E1ED0-F92F-4740-9310-4D80561F7571Q37973811-3AACA5A2-5281-41E9-A659-409673DF5E22Q38033116-A2EF1CC6-31DC-4790-BBA3-82ECB67A8199Q38076281-BBD2903C-9FBD-45DF-BD73-9CE64D667ECDQ38099273-14D57E1D-DB93-4182-99FE-20C388ED0B26Q38514715-5BC53B33-ED4C-4CD5-9E93-61D4059113C9Q38598965-02E3D758-48BB-46B8-B288-FC2CAEB5A81D
P2860
Altered Runx1 subnuclear targeting enhances myeloid cell proliferation and blocks differentiation by activating a miR-24/MKP-7/MAPK network.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Altered Runx1 subnuclear targe ...... g a miR-24/MKP-7/MAPK network.
@ast
Altered Runx1 subnuclear targe ...... g a miR-24/MKP-7/MAPK network.
@en
Altered Runx1 subnuclear targe ...... g a miR-24/MKP-7/MAPK network.
@nl
type
label
Altered Runx1 subnuclear targe ...... g a miR-24/MKP-7/MAPK network.
@ast
Altered Runx1 subnuclear targe ...... g a miR-24/MKP-7/MAPK network.
@en
Altered Runx1 subnuclear targe ...... g a miR-24/MKP-7/MAPK network.
@nl
prefLabel
Altered Runx1 subnuclear targe ...... g a miR-24/MKP-7/MAPK network.
@ast
Altered Runx1 subnuclear targe ...... g a miR-24/MKP-7/MAPK network.
@en
Altered Runx1 subnuclear targe ...... g a miR-24/MKP-7/MAPK network.
@nl
P2093
P2860
P1433
P1476
Altered Runx1 subnuclear targe ...... g a miR-24/MKP-7/MAPK network.
@en
P2093
Andre J van Wijnen
Christopher R Dowdy
Gary S Stein
Jane B Lian
Janet L Stein
Sayyed K Zaidi
P2860
P304
P356
10.1158/0008-5472.CAN-09-1567
P407
P577
2009-10-13T00:00:00Z